Kellyanne Conway was announced as the president’s choice to lead the White House’s opioid crisis efforts in November of 2017. Kellyanne Conway, however, has ZERO experience in drug policy or enforcement. It begs the question: How serious is the White House about implementing positive and effective change in the opioid crisis by appointing Kellyanne Conway as the "Drug Czar?" The political appointees of her “opioid cabinet” have no more experience in drug policy or enforcement than she does. Americans have seen it before with the “War on Poverty” and “War on Drugs?” We know how those turned out. America's opioid crisis requires effective, professional and responsible policy-making and leadership.
America's dealings in the pharmaceutical, addiction and treatment industry is highly questionable: